Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Preveceutical Medical Inc PRVCF


Primary Symbol: C.PREV

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based... see more

Recent & Breaking News (CSE:PREV)

PreveCeutical Develops Proprietary Extraction Protocol for Medical Cannabinoids to be Used with the Sol-gel Drug Delivery Program

Newsfile September 4, 2018

PreveCeutical Provides Corporate Update

Newsfile August 22, 2018

PreveCeutical Signs Licensing Agreement on Health Products

Stockhouse Editorial August 15, 2018

PreveCeutical Signs Agreement with Asterion Cannabis Inc. to License Natural Health Products and Engages Monster Media, LLC to Provide Investor Relations Services

Newsfile August 15, 2018

PreveCeutical Announces First Cannabis Product for Treatment of Anxiety

Newsfile August 8, 2018

PreveCeutical Provides Update on Second Phase of Scorpion Venom-Derived Peptide Program

Newsfile July 31, 2018

PreveCeutical Announces Launch of Cannabis Division

Newsfile July 24, 2018

PreveCeutical Updates on Sol-gel Drug Program

Stockhouse Editorial July 11, 2018

PreveCeutical Provides Update on Sol-gel Drug Delivery Program

Newsfile July 11, 2018

PreveCeutical Retains Link Media LLC to Provide Marketing Services

Newsfile July 10, 2018

PreveCeutical Announces the Closing of Oversubscribed Non-Brokered Private Placement

Newsfile June 29, 2018

NetworkNewsWire Releases Exclusive Audio Interview with PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H)

GlobeNewswire June 26, 2018

PreveCeutical Announces Oversubscribed Non-Brokered Private Placement

Newsfile June 25, 2018

PreveCeutical Amends Terms of Warrants to Extend Expiry Date

Newsfile June 8, 2018

PreveCeutical Engages Stadnyk & Partners to Provide Market Awareness and Strategic Advisory Services

Newsfile June 5, 2018

IIROC Trade Resumption - PREV

Canada NewsWire May 24, 2018

IIROC Trade Resumption - PREV

Canada NewsWire May 23, 2018

PreveCeutical Provides Update on Forward Stock Split

Newsfile May 23, 2018

IIROC Trading Halt - PREV

Canada NewsWire May 23, 2018

PreveCeutical Shareholders Approve Five-for-One Forward Stock Split

Newsfile May 17, 2018